Stock RVMD REVOLUTION MEDICINES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Revolution Medicines, Inc.

Equities

RVMD

US76155X1000

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
40.68 USD +2.25% Intraday chart for Revolution Medicines, Inc. +7.88% +41.84%
Jun. 05 Revolution Medicines Insider Sold Shares Worth $299,942, According to a Recent SEC Filing MT
May. 09 Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating MT

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Revolution Medicines, Inc., Q1 2024 Earnings Call, May 08, 2024
Transcript : Revolution Medicines, Inc., Q4 2023 Earnings Call, Feb 26, 2024
Transcript : Revolution Medicines, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 11:15 AM
Transcript : Revolution Medicines, Inc., Q3 2023 Earnings Call, Nov 06, 2023
Transcript : Revolution Medicines, Inc. - Special Call
Transcript : Revolution Medicines, Inc., Q2 2023 Earnings Call, Aug 08, 2023
Transcript : EQRx, Inc., Revolution Medicines, Inc. - M&A Call
Transcript : Revolution Medicines, Inc. Presents at Barclays Virtual Fireside Chat Series, Jun-15-2023 12:00 PM
Transcript : Revolution Medicines, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-14-2023 08:40 AM
Transcript : Revolution Medicines, Inc., Q1 2023 Earnings Call, May 08, 2023
Transcript : Revolution Medicines, Inc., Q4 2022 Earnings Call, Feb 27, 2023
Transcript : Revolution Medicines, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 11:15 AM
Transcript : Revolution Medicines, Inc., Q3 2022 Earnings Call, Nov 07, 2022
Revolution Medicines, Inc. Provides Earnings Guidance for the Full Year 2022
CI
Transcript : Revolution Medicines, Inc., Q2 2022 Earnings Call, Aug 09, 2022
Revolution Medicines, Inc. Provides Earnings Guidance for the Year 2022
CI
Transcript : Revolution Medicines, Inc. Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, Jun-15-2022 01:20 PM
Transcript : Revolution Medicines, Inc., Q1 2022 Earnings Call, May 09, 2022
Revolution Medicines, Inc. Reiterates Earnings Guidance for the Full Year 2022
CI
Transcript : Revolution Medicines, Inc., Q4 2021 Earnings Call, Feb 28, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RVMD Stock
  4. News Revolution Medicines, Inc.
  5. Transcripts